Our aging population deserves better heart care, but are we doing enough?
The recent AHA 2025 Scientific Sessions shed light on a pressing issue: cardiovascular care for older adults is lagging behind. Experts highlighted three key areas where we need to do better: embracing digital tools, making clinical trials more inclusive, and rethinking medication regimens. But here's where it gets controversial: simply throwing technology at the problem isn't enough.
Digital Health: A Double-Edged Sword?
Dr. John A. Dodson from NYU pointed out that while mobile health apps hold promise for managing hypertension, older adults face significant barriers. Physical limitations like vision and hearing loss, cognitive decline, and the sheer frustration of learning new technology can make these tools inaccessible. And this is the part most people miss: even when older adults are willing, the 'utility cost' – the perceived effort versus benefit – can be a major deterrent.
Dodson's research, including the RESILIENT trial, showed that digital cardiac rehab only worked for highly engaged patients. This raises questions: How do we design digital tools that are truly user-friendly for older adults? And how do we ensure they're motivated to use them consistently?
Trials Need to Reflect Reality
Dr. Michael Nanna from Yale University tackled the underrepresentation of older adults in coronary artery disease research. Strict inclusion criteria often exclude them due to comorbidities, frailty, or logistical challenges. Nanna argues that this leads to findings that don't apply to the very population most affected by heart disease. The LIVEBETTER study, which prioritizes patient and caregiver input and focuses on quality of life, offers a more inclusive model. But will the medical community embrace this shift?
The Medication Maze: Less Can Be More
Dr. Mark Effron from Ochsner Health highlighted the dangers of polypharmacy in older adults. While medications are essential, the cumulative burden can lead to adverse effects, falls, and even worsen cardiovascular health. Effron advocates for deprescribing – carefully reducing medications when appropriate. Studies like the Veterans Affairs trial and the OPTIMISE trial show promising results, but will doctors be willing to challenge the 'more is better' mindset?
The Future of Heart Care for Seniors
The AHA 2025 sessions paint a clear picture: we need a paradigm shift in cardiovascular care for older adults. This means designing digital tools with their needs in mind, making clinical trials truly representative, and embracing a less-is-more approach to medication. But it also requires a fundamental change in how we view aging – not as a decline, but as a stage of life that deserves personalized, patient-centered care.
What do you think? Are we doing enough to address the unique needs of older adults with heart disease? Share your thoughts in the comments below.
